The endocannabinoid system in social anxiety disorder: from pathophysiology to novel therapeutics

Social anxiety disorder (SAD) is a highly prevalent psychiatric disorder that presents with an early age of onset, chronic disease course, and increased risk of psychiatric comorbidity. Current treatment options for SAD are associated with low response rates, suboptimal efficacy, and possible risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Mashal, Boileau, Isabelle, Le Foll, Bernard, Carvalho, Andre F., Kloiber, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827369/
https://www.ncbi.nlm.nih.gov/pubmed/34468550
http://dx.doi.org/10.1590/1516-4446-2021-1926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827369/
https://www.ncbi.nlm.nih.gov/pubmed/34468550
http://dx.doi.org/10.1590/1516-4446-2021-1926

Ejemplares similares